• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EstoniaChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic spontaneous urticaria
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
Pulmonology
5 min
interactivity

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

Type 2 Inflammation Within Skin Tissue in AD
Dermatology
4 min
expert video

Type 2 Inflammation Within Skin Tissue in AD

IL-4 Contributes to Systemic Type 2 Inflammation in AD
Dermatology
4 min
expert video

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Considerations for Disease Modification in AD
Dermatology
3 min
expert video

Considerations for Disease Modification in AD

How Can FeNO Measurement Improve Severe Asthma Management?
Pulmonology
7 min
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD
Dermatology
23 min
Podcast

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD

Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
Pulmonology
5 min
interactivity

Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
24 min
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

ADVENT On Air | Loss of Smell in CRSwNP Patients
Rhinology
15 min
Podcast

ADVENT On Air | Loss of Smell in CRSwNP Patients

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
5 min
interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

    1
    ...
    101112